Constitution & Bylaws Local Chapters & Events Secure Membership Form
Ohio Society of Health System Pharmacists



Main Menu
Home
Membership Info
News
Divisions
Chapters
Online Resources
Partners
Corporate Partnerships
Contact Us
Upcoming Events
Advertising
Scholarships
Awards
Online CE
Latest News




Newsflash


 
OSHP Members to Receive FASHP Designation PDF Print E-mail
Written by Bob Parsons   
Wednesday, 20 May 2009

Two OSHP members are slated to receive Fellow of the American Society of Health-System Pharmacists (FASHP) designations for 2009. They are Dale English II, BSPh, PharmD, of Northeastern Ohio Universities College of Pharmacy, and Niesha Griffith, BSPh, M.S., The Ohio State University Medical Center.  They will be honored on Tuesday, June 16, during the ASHP Summer Meeting in Rosemont, IL.

This program recognizes excellence in practice and promotes public awareness of outstanding pharmacists.  Each applicant's credentials are assessed against rigorous criteria that include contributions to the scientific literature, research, education, and active involvement and leadership in professional activities.  The program has recognized 619 Fellows since it began in 1988.

 

 


Pharmacy News
ASHP Health-System Pharmacy News
  • Dronedarone Approved for Atrial Arrhythmias
    FDA today announced the approval of the oral antiarrhythmia drug dronedarone for the maintenance of normal heartbeat in certain patients with a history of paroxysmal or persistent atrial fibrillation or atrial flutter.
  • Ferumoxytol Approved for Iron Deficiency Anemia
    AMAG Pharmaceuticals announced Tuesday that it has received FDA's approval to market ferumoxytol injection for the treatment of iron deficiency anemia in adults with chronic kidney disease.
  • Mental Health Warnings Increase for Bupropion, Varenicline
    FDA announced today that the makers of bupropion and varenicline products must more prominently display warnings about the risk of serious mental health events occurring during therapy.
  • Theft Prompts Astellas Product Lot Withdrawal
    Astellas Pharma US Inc. is withdrawing from the market 22 specific lots of eight products that were stolen from a transport trailer earlier this month, the company announced (PDF) yesterday.
  • Risk-Management Plan for Opioid Drugs Proves Slow Going
    FDA officials recently acknowledged the enormity of a task that the agency set for itself in February?creating a risk evaluation and mitigation strategy, or REMS, to ensure the safe use of long-acting and extended-release opioid drugs.






HealthSystemCE.org
Log In/Out





Lost Password?
No account yet? Register
Events Calendar
« < July 2009 > »
S M T W T F S
28 29 30 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1

 Partners
Advertisement